Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heying Duan

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Clinical Nuclear Medicine|May 21, 2020
The Effect of Various β Values on Image Quality and Semiquantitative Measurements in 68Ga-RM2 and 68Ga-PSMA-11 PET/MRI Images Reconstructed With a Block Sequential Regularized Expectation Maximization AlgorithmLucia Baratto, Heying Duan, Valentina Ferri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 21, 2014
The role of SPECT/CT in radioembolization of liver tumoursHojjat Ahmadzadehfar, Heying Duan, Alexander R Haug, et al.
Radiology Case Reports|October 29, 2020
Pulmonary large cell neuroendocrine carcinoma (LCNEC) with confirmed liver metastases negative on <sup>18</sup>F-FDG and <sup>68</sup>Ga-DOTATATE PETGaia Ninatti, Heying Duan, Valentina Ferri, et al.
Clinical Nuclear Medicine|June 13, 2022
Striking Size Reduction of Rapidly Growing Pancreatic Neuroendocrine Carcinoma Metastatic Nodal Conglomerate After Only 2 Cycles of 177 Lu-DOTATATEEduardo A Somoza, Heying Duan, Shagufta Shaheen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 9, 2023
Modified PROMISE criteria for standardized interpretation of gastrin-releasing peptide receptor (GRPR)-targeted PETHeying Duan, Guido A Davidzon, Farshad Moradi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2019
Physiological <sup>68</sup>Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurementsLucia Baratto, Heying Duan, Riccardo Laudicella, et al.
Translational Oncology|November 25, 2021
<sup>68</sup>Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectorsHeying Duan, Lucia Baratto, Negin Hatami, et al.
The Oncologist|September 2, 2018
Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin AnalogsBarbara Kiesewetter, Heying Duan, Wolfgang Lamm, et al.
AJR. American Journal of Roentgenology|August 18, 2021
Reduced Acquisition Time per Bed Position for PET/MRI Using <sup>68</sup>Ga-RM2 or <sup>68</sup>Ga-PSMA-11 in Patients With Prostate Cancer: A Retrospective AnalysisHeying Duan, Lucia Baratto, Negin Hatami, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 25, 2024
Prospective Comparison of <sup>68</sup>Ga-NeoB and <sup>68</sup>Ga-PSMA-R2 PET/MRI in Patients with Biochemically Recurrent Prostate CancerHeying Duan, Hong Song, Guido A Davidzon, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Clinical Nuclear Medicine|May 21, 2020
The Effect of Various β Values on Image Quality and Semiquantitative Measurements in 68Ga-RM2 and 68Ga-PSMA-11 PET/MRI Images Reconstructed With a Block Sequential Regularized Expectation Maximization AlgorithmLucia Baratto, Heying Duan, Valentina Ferri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 21, 2014
The role of SPECT/CT in radioembolization of liver tumoursHojjat Ahmadzadehfar, Heying Duan, Alexander R Haug, et al.
Radiology Case Reports|October 29, 2020
Pulmonary large cell neuroendocrine carcinoma (LCNEC) with confirmed liver metastases negative on <sup>18</sup>F-FDG and <sup>68</sup>Ga-DOTATATE PETGaia Ninatti, Heying Duan, Valentina Ferri, et al.
Clinical Nuclear Medicine|June 13, 2022
Striking Size Reduction of Rapidly Growing Pancreatic Neuroendocrine Carcinoma Metastatic Nodal Conglomerate After Only 2 Cycles of 177 Lu-DOTATATEEduardo A Somoza, Heying Duan, Shagufta Shaheen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 9, 2023
Modified PROMISE criteria for standardized interpretation of gastrin-releasing peptide receptor (GRPR)-targeted PETHeying Duan, Guido A Davidzon, Farshad Moradi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2019
Physiological <sup>68</sup>Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurementsLucia Baratto, Heying Duan, Riccardo Laudicella, et al.
Translational Oncology|November 25, 2021
<sup>68</sup>Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectorsHeying Duan, Lucia Baratto, Negin Hatami, et al.
The Oncologist|September 2, 2018
Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin AnalogsBarbara Kiesewetter, Heying Duan, Wolfgang Lamm, et al.
AJR. American Journal of Roentgenology|August 18, 2021
Reduced Acquisition Time per Bed Position for PET/MRI Using <sup>68</sup>Ga-RM2 or <sup>68</sup>Ga-PSMA-11 in Patients With Prostate Cancer: A Retrospective AnalysisHeying Duan, Lucia Baratto, Negin Hatami, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 25, 2024
Prospective Comparison of <sup>68</sup>Ga-NeoB and <sup>68</sup>Ga-PSMA-R2 PET/MRI in Patients with Biochemically Recurrent Prostate CancerHeying Duan, Hong Song, Guido A Davidzon, et al.
Pageof 5